Vimarsana
Biggest News Aggregation in the World

Page 14 - Jonathan Milner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jonathan Milner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jonathan Milner Today - Breaking & Trending Today

PharmEnable Closes $7.5M Financing led by MP Healthcare to Develop Next Generation of Small Molecule Drugs to Treat Cancer and Neurological Diseases - Vimarsana News

PharmEnable Closes $7.5M Financing led by MP Healthcare to Develop Next Generation of Small Molecule Drugs to Treat Cancer and Neurological Diseases

PharmEnable, a drug discovery company focused on chemical novelty, diversity and complexity, announces it has closed a Pre-Series A investment round of $7.5M to develop the next generation of small molecule drugs against disease areas of high clinical need. The funding round was led by MP Healthcare Venture ...

Scarlet Therapeutics gains funding for blood cell platform - Vimarsana News

Scarlet Therapeutics gains funding for blood cell platform

Vital financing will allow the company to build a pipeline of novel therapies targeting serious conditions - News - PharmaTimes

PharmEnable Closes $7.5M Pre-Series Financing - Vimarsana News

PharmEnable Closes $7.5M Pre-Series Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Five things for pharma marketers to know: Thursday, May 18, 2023 - Vimarsana News

Five things for pharma marketers to know: Thursday, May 18, 2023

Abcam founder Jonathan Milner seeks to oust the chairman of the biotech supplier; PTC Therapeutics’ phenylketonuria drug met its key goal in a Phase 3 study.

Abcam PLC: Statement on potential Extraordinary General Meeting - Vimarsana News

Abcam PLC: Statement on potential Extraordinary General Meeting

/PRNewswire/ -- Abcam plc (Nasdaq: ABCM), ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today...